Anti-Renal Cell Carcinoma (RCC)


This antibody binds to a 200 kDa glycoprotein localized in the brush border of the proximal renal tubule in Renal Cell Carcinoma. This antibody immunoreacts with approximately 90% of primary renal cell carcinomas and approximately 85% of metastatic renal cellcarcinomas. Other tumors that may react with this antibody are parathyroid adenoma, an occasional breast carcinoma. Nephroblastoma, oncocytoma, mesoblastic nephroma, transitional cell carcinoma, and angiomyolipoma are not labeled with this antibody.
Intended Use: IVD
Antibody Type: Monoclonal
Clone: RCC-26
Source: Mouse
Tissue Type/Cancer Type: Renal Cell Carcinoma